First Light Asset Management, LLC Neogenomics Inc Transaction History

First Light Asset Management, LLC

$1.1 Billion
Q2 2024

A detailed history of First Light Asset Management, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, First Light Asset Management, LLC holds 3,782,561 shares of NEO stock, worth $51 Million. This represents 4.78% of its overall portfolio holdings.

Number of Shares

3,782,561

Previous 3,302,165 14.55%

Holding current value

$51 Million

Previous $51.9 Million 1.07%

% of portfolio

4.78%

Previous 4.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.01 - $15.77 $6.25 Million - $7.58 Million	480,396 Added 14.55%	3,782,561 $52.5 Million
Q1 2024 May 15, 2024	SELL	$14.06 - $16.79 $8.78 Million - $10.5 Million	-624,591 Reduced 15.91%	3,302,165 $51.9 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $14.4 Million - $25.6 Million	1,234,699 Added 45.86%	3,926,756 $63.5 Million
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $97,304 - $136,846	-6,901 Reduced 0.26%	2,692,057 $43.3 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $152,593 - $326,507	16,787 Added 0.63%	2,698,958 $47 Million
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $244,635 - $457,790	-37,928 Reduced 1.39%	2,682,171 $24.8 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $36,250 - $59,540	4,612 Added 0.17%	2,720,099 $23.4 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $13.97 $13.5 Million - $26.7 Million	1,909,529 Added 236.93%	2,715,487 $22.1 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $510,919 - $1.48 Million	42,051 Added 5.5%	805,958 $9.79 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $8.9 Million - $14.2 Million	-292,053 Reduced 27.66%	763,907 $26.1 Million
Q3 2021 Nov 12, 2021	SELL	$41.66 - $52.52 $3.87 Million - $4.88 Million	-92,985 Reduced 8.09%	1,055,960 $50.9 Million
Q2 2021 Aug 13, 2021	BUY	$36.62 - $51.69 $5.34 Million - $7.53 Million	145,729 Added 14.53%	1,148,945 $51.9 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $20.2 Million - $29.1 Million	486,125 Added 94.01%	1,003,216 $48.4 Million
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $3.46 Million - $5.42 Million	-96,011 Reduced 15.66%	517,091 $27.8 Million
Q3 2020 Nov 13, 2020	BUY	$33.26 - $40.48 $13,969 - $17,001	420 Added 0.07%	613,102 $22.6 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $48,855 - $62,598	2,018 Added 0.33%	612,682 $19 Million
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $14.9 Million - $25.1 Million	-726,285 Reduced 54.32%	610,664 $16.9 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $326,168 - $513,337	17,203 Added 1.3%	1,336,949 $39.1 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $111,584 - $153,136	-5,836 Reduced 0.44%	1,319,746 $25.2 Million
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $5.46 Million - $6.72 Million	-279,029 Reduced 17.39%	1,325,582 $29.1 Million
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $7.33 Million - $12.3 Million	-603,577 Reduced 27.33%	1,604,611 $32.8 Million
Q4 2018 Feb 14, 2019	SELL	$11.24 - $18.5 $16.8 Million - $27.6 Million	-1,492,739 Reduced 40.33%	2,208,188 $27.8 Million
Q3 2018 Nov 14, 2018	SELL	$12.5 - $15.38 $18.3 Million - $22.5 Million	-1,461,136 Reduced 28.31%	3,700,927 $56.8 Million
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $3.21 Million - $5.64 Million	401,731 Added 8.44%	5,162,063 $67.7 Million
Q1 2018 May 15, 2018	BUY	$7.23 - $8.76 $6.6 Million - $8 Million	912,730 Added 23.72%	4,760,332 $38.8 Million
Q4 2017 Feb 14, 2018	BUY	$8.02 - $11.18 $11.5 Million - $16.1 Million	1,439,672 Added 59.79%	3,847,602 $34.1 Million
Q3 2017 Nov 14, 2017	SELL	$9.11 - $11.26 $2.47 Million - $3.06 Million	-271,341 Reduced 10.13%	2,407,930 $26.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,679,271	2,679,271 $24 Million

Others Institutions Holding NEO

# of Institutions

276

Shares Held

127M

Call Options Held

581K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.7B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.

Account

First Light Asset Management, LLC Neogenomics Inc Transaction History